Literature DB >> 31365195

High Prevalence of Metabolic Syndrome Among Adolescents and Young Adults With Bipolar Disorder.

Christine Li1,2, Boris Birmaher3, Brian Rooks3, Mary Kay Gill3, Heather Hower4, David A Axelson5, Daniel P Dickstein4,6, Tina R Goldstein3, Fangzi Liao3, Shirley Yen4,7,8, Jeffrey Hunt4,6, Satish Iyengar9, Neal D Ryan3, Michael A Strober10, Martin B Keller7, Benjamin I Goldstein11,1,2.   

Abstract

OBJECTIVE: Despite abundant literature demonstrating increased metabolic syndrome (MetS) prevalence and important clinical correlates of MetS among middle-age adults with bipolar disorder, little is known about this topic among adolescents and young adults early in their course of bipolar disorder. We therefore examined this topic in the Course and Outcome of Bipolar Youth (COBY) study.
METHODS: A cross-sectional, retrospective study was conducted of 162 adolescents and young adults (mean ± SD age = 20.8 ± 3.7 years; range, 13.6-28.3 years) with bipolar disorder (I, II, or not otherwise specified, based on DSM-IV) enrolled in COBY between 2000 and 2006. MetS measures (blood pressure, glucose, high-density lipoprotein cholesterol [HDL-C], triglycerides, and waist circumference), defined using the International Diabetes Federation criteria, were obtained at a single timepoint. Mood, comorbidity, and treatment over the 6 months preceding the MetS assessment were evaluated using the Longitudinal Interval Follow-Up Evaluation.
RESULTS: The prevalence of MetS in the sample was 19.8% (32/162). Low HDL-C (56.5%) and abdominal obesity (46.9%) were the most common MetS criteria. MetS was nominally associated with lower lifetime global functioning at COBY intake (odds ratio [OR] = 0.97, P = .06). MetS was significantly associated with percentage of weeks in full-threshold pure depression (OR = 1.07, P = .02) and percentage of weeks receiving antidepressant medications (OR = 1.06, P = .001) in the preceding 6 months. MetS was not associated with manic symptoms or medications other than antidepressants.
CONCLUSIONS: The prevalence of MetS in this sample was at least double compared to the general population. Moreover, MetS is associated with increased burden of depression symptoms in this group. Management of early-onset bipolar disorder should integrate strategies focused on modifying MetS risk factors. © Copyright 2019 Physicians Postgraduate Press, Inc.

Entities:  

Year:  2019        PMID: 31365195      PMCID: PMC6802953          DOI: 10.4088/JCP.18m12422

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  62 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

2.  Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data.

Authors:  J Kaufman; B Birmaher; D Brent; U Rao; C Flynn; P Moreci; D Williamson; N Ryan
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1997-07       Impact factor: 8.829

Review 3.  Bipolar disorder and metabolic syndrome: an international perspective.

Authors:  Roger S McIntyre; Marlon Danilewitz; Samantha S Liauw; David E Kemp; Ha T T Nguyen; Linda S Kahn; Aaron Kucyi; Joanna K Soczynska; Hanna O Woldeyohannes; Angela Lachowski; Byungsu Kim; Jay Nathanson; Mohammad Alsuwaidan; Valerie H Taylor
Journal:  J Affect Disord       Date:  2010-06-12       Impact factor: 4.839

4.  Age-specific prevalence of metabolic syndrome in Italian patients with bipolar disorder.

Authors:  Virginio Salvi; Virginia D'Ambrosio; Gianluca Rosso; Filippo Bogetto; Giuseppe Maina
Journal:  Psychiatry Clin Neurosci       Date:  2011-02       Impact factor: 5.188

5.  The burden of obesity among adults with bipolar disorder in the United States.

Authors:  Benjamin I Goldstein; Shang-Min Liu; Nevena Zivkovic; Ayal Schaffer; Lung-Chang Chien; Carlos Blanco
Journal:  Bipolar Disord       Date:  2011-06       Impact factor: 6.744

6.  Clinical features of bipolar disorder with and without comorbid diabetes mellitus.

Authors:  Martina Ruzickova; Claire Slaney; Julie Garnham; Martin Alda
Journal:  Can J Psychiatry       Date:  2003-08       Impact factor: 4.356

7.  Metabolic syndrome and metabolic abnormalities in bipolar disorder: a meta-analysis of prevalence rates and moderators.

Authors:  Davy Vancampfort; Kristof Vansteelandt; Christoph U Correll; Alex J Mitchell; Amber De Herdt; Pascal Sienaert; Michel Probst; Marc De Hert
Journal:  Am J Psychiatry       Date:  2013-03       Impact factor: 18.112

8.  Modal subcomponents of metabolic syndrome in patients with bipolar disorder.

Authors:  Jeffrey Cardenas; Mark A Frye; Susan L Marusak; Eric M Levander; Jason W Chirichigno; Stryder Lewis; Shoshanna Nakelsky; Sun Hwang; Jim Mintz; Lori L Altshuler
Journal:  J Affect Disord       Date:  2007-07-12       Impact factor: 4.839

9.  Preliminary findings regarding overweight and obesity in pediatric bipolar disorder.

Authors:  Benjamin I Goldstein; Boris Birmaher; David A Axelson; Tina R Goldstein; Christianne Esposito-Smythers; Michael A Strober; Jeffrey Hunt; Henrietta Leonard; Mary Kay Gill; Satish Iyengar; Colleen Grimm; Mei Yang; Neal D Ryan; Martin B Keller
Journal:  J Clin Psychiatry       Date:  2008-11-18       Impact factor: 4.384

10.  The Longitudinal Interval Follow-up Evaluation. A comprehensive method for assessing outcome in prospective longitudinal studies.

Authors:  M B Keller; P W Lavori; B Friedman; E Nielsen; J Endicott; P McDonald-Scott; N C Andreasen
Journal:  Arch Gen Psychiatry       Date:  1987-06
View more
  7 in total

1.  The clinical characterization of the adult patient with bipolar disorder aimed at personalization of management.

Authors:  Roger S McIntyre; Martin Alda; Ross J Baldessarini; Michael Bauer; Michael Berk; Christoph U Correll; Andrea Fagiolini; Kostas Fountoulakis; Mark A Frye; Heinz Grunze; Lars V Kessing; David J Miklowitz; Gordon Parker; Robert M Post; Alan C Swann; Trisha Suppes; Eduard Vieta; Allan Young; Mario Maj
Journal:  World Psychiatry       Date:  2022-10       Impact factor: 79.683

2.  Risk factors of hospitalization for any medical condition among patients with prior emergency department visits for mental health conditions.

Authors:  Louise Penzenstadler; Lia Gentil; Guy Grenier; Yasser Khazaal; Marie-Josée Fleury
Journal:  BMC Psychiatry       Date:  2020-09-03       Impact factor: 3.630

Review 3.  Call to action regarding the vascular-bipolar link: A report from the Vascular Task Force of the International Society for Bipolar Disorders.

Authors:  Benjamin I Goldstein; Bernhard T Baune; David J Bond; Pao-Huan Chen; Lisa Eyler; Andrea Fagiolini; Fabiano Gomes; Tomas Hajek; Jessica Hatch; Susan L McElroy; Roger S McIntyre; Miguel Prieto; Louisa G Sylvia; Shang-Ying Tsai; Andrew Kcomt; Jess G Fiedorowicz
Journal:  Bipolar Disord       Date:  2020-06-08       Impact factor: 6.744

4.  Changes in the Prevalence of Metabolic Syndrome and Its Components as Well as in Relevant Preventive Medication between 2006 and 2018 in the Northeast Hungarian Population.

Authors:  Peter Piko; Judit Dioszegi; Janos Sandor; Roza Adany
Journal:  J Pers Med       Date:  2021-01-16

Review 5.  Drugs, Guts, Brains, but Not Rock and Roll: The Need to Consider the Role of Gut Microbiota in Contemporary Mental Health and Wellness of Emerging Adults.

Authors:  Ju Eun Lee; David Walton; Colleen P O'Connor; Michael Wammes; Jeremy P Burton; Elizabeth A Osuch
Journal:  Int J Mol Sci       Date:  2022-06-14       Impact factor: 6.208

6.  Twelve-month outcomes in overweight/obese users with mental disorders following a multi-element treatment including diet, physical activity, and positive thinking: The real-world "An Apple a Day" controlled trial.

Authors:  Laura Giusti; Valeria Bianchini; Annalisa Aggio; Silvia Mammarella; Anna Salza; Stefano Necozione; Alessia Alunno; Claudio Ferri; Massimo Casacchia; Rita Roncone
Journal:  Front Psychiatry       Date:  2022-08-23       Impact factor: 5.435

7.  Identification of inflammatory subgroups of schizophrenia and bipolar disorder patients with HERV-W ENV antigenemia by unsupervised cluster analysis.

Authors:  Ryad Tamouza; Urs Meyer; Marianne Foiselle; Jean-Romain Richard; Ching-Lieng Lu; Wahid Boukouaci; Philippe Le Corvoisier; Caroline Barrau; Alexandre Lucas; Hervé Perron; Marion Leboyer
Journal:  Transl Psychiatry       Date:  2021-07-06       Impact factor: 6.222

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.